Cancer drug prediction has yet to embrace the open-source movement, Georgia Tech researchers write. This week, they made public a machine learning platform that has built predictive models for 9 drugs. They don't care if people make money off the algorithm, as long as they advance treatments.

Cancer drug prediction has yet to embrace the open-source movement, Georgia Tech researchers write. This week, they made public a machine learning platform that has built predictive models for 9 drugs. They don't care if people make money off the algorithm, as long as they advance treatments.

octubre 31, 2017

http://ift.tt/2ygXX4O via /r/science http://ift.tt/2lz22Lu http://ift.tt/2ygXX4O

Comentarios